Active Ingredient(s): Glycopyrrolate
FDA Approved: * July 28, 2010
Pharm Company: * SHIONOGI PHARMA
Category: Ulcer

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has few to no central effects. It is available in oral, intravenous, topical, and inhaled forms. It is a synthetic quaternary ammonium compound. The cation, which is the active moiety, is called glycopyrronium (INN)[1] or glycopyrrolate (USAN). In June 2018, glycopyrronium was approved by the FDA to treat excessive underarm sweating,... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cuvposa 1 mg/5ml Oral Liquid
NDC: 0259-0501
Merz Pharmaceuticals, LLC
Cuvposa 1 mg/5ml Oral Solution
NDC: 59630-206
Shionogi Pharma, Inc.

Related Brands

Drugs with the same active ingredients